Artelo Biosciences, Inc. (ARTL) Misses Q2 EPS by 548c

Artelo Biosciences, Inc. (NASDAQ: ARTL) reported Q2 EPS of ($5.61), $5.48 worse than the analyst estimate of ($0.13).

For earnings history and earnings-related data on Artelo Biosciences, Inc. (ARTL) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• BW LPG Limited (BWLP) Reports Q1 EPS of $0.79
• Chagee Holdings (CHA) Tops Q2 EPS by 3c